Filter  |  August 30, 2021

Eric Lindblom, a senior scholar at Georgetown’s O’Neill Institute for National and Global Health Law and a former director of the FDA’s Center for Tobacco Products Office of Policy, explained recently to Filter that the FDA typically waits to act until a “crisis” emerges or Congress orders the agency to do something. (With vaping, for example, it was the spiraling outcry around teen use.)

Read more here.